ACTA1 and myalgic encephalomeyelitis/chronic fatigue syndrome: Similarly, the IF results demonstrated that the miR-450a-2-3p mimic significantly inhibited the α-SMA overexpression in TGF-β1-induced CFs (Figure 5(q)), whereas the opposite was observed in the miR-450a-2-3p inhibitor group (Figure 5(r)).